Literature DB >> 11957154

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.

Michael Steurer1, Reinhard Stauder, Kurt Grünewald, Eberhard Gunsilius, Hans-Christoph Duba, Guenther Gastl, Stephan Dirnhofer.   

Abstract

Hepatosplenic gammadelta-T-cell lymphoma (HSTCL) is a rare extranodal T-cell non-Hodgkin's lymphoma (T-NHL) with only 46 well-documented cases in medical literature. Notably, a relatively high number of these case reports (15%) describe the occurrence of HSTCL after solid organ transplantation. We describe the case of a 45-year-old man who developed a leukemic HSTCL 5 years after renal transplantation and continous immunosuppression with cyclosporine A and prednisolone. After a rapid clinical course, the patient died and autopsy was performed. The malignant lymphocytes showed a natural killer-like gammadelta-T-cell phenotype (CD2(+), CD3(+), CD7(+), TCR gammadelta(+), CD56(+), TIA-1(+), CD4(-), CD8(-), and TCR alphabeta(-)) and infiltrated the sinusoids of liver and the red pulp of the spleen. Cytogenetically, an isochromosome 7q, trisomy 8, Y-loss, and a translocation t(1;4) was detectable. This case shows the difficulties of recognizing HSTCL early in the clinical course and underlines that all types of T-NHL, nodal as well as extranodal, have to be considered in the differential diagnosis of posttransplantation lymphoproliferative disorders. Moreover, HSTCL seems to occur as a specific late complication of solid organ transplantation. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11957154     DOI: 10.1053/hupa.2002.31301

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

2.  Hepatosplenic T cell lymphoma: a unifying entity in a patient with hemolytic anemia, massive splenomegaly, and liver dysfunction.

Authors:  Marianna Mavilia; Agnes McAuliffe; Safina Hafeez; Haleh Vaziri
Journal:  Clin J Gastroenterol       Date:  2018-05-15

3.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

4.  Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery.

Authors:  Marjana Glaser; Aleš Goropevšek; Rajko Kavalar; Andrej Glaser
Journal:  Hematol Rep       Date:  2012-02-28

5.  Role of Imaging in Diagnosis of a Rare Hepatosplenic Gamma Delta T-Cell Lymphoma during Pregnancy: A Case Report and Review of Literature.

Authors:  Reda R H Youssef; Amr Elmahdy; Samah Kohla; Feryal Ibrahim; Ahmed Saied Sabry; Amal Alobaidly; Nehal Saloum
Journal:  Case Rep Oncol       Date:  2019-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.